Pirmitegravir demonstrates proof of concept in HIV

At IDWeek 2025, held on 19-22 October, Xue Meng from ST Pharm presented results from a proof of concept clinical trial for ST Pharm’s investigational human immunodeficiency virus-1 (HIV-1) allosteric…